Germany
Update notification · 14.08.2026
Supply shortage: Telmisartan Micro Labs 20 mg Tabletten
Affected country: Germany · Reported period: 18.02.2026 – 04.09.2026 · Active ingredient: Telmisartan
CountryGermany
PZN13881321
ENR2198054
Notification typeUpdate notification
Start18.02.2026
Expected end04.09.2026
Last update14.08.2026
ReasonOther
ATCC09CA07
Hospital-relevantYes
Notice context
A supply shortage has been recorded for Telmisartan Micro Labs 20 mg Tabletten in Germany. The stated reason is “Other”. The notice concerns the active ingredient Telmisartan and is identified as hospital-relevant.
This information describes the reported supply status and is not medical or pharmaceutical treatment advice. Availability, alternatives and further measures must be assessed for each individual case by the responsible pharmaceutical market participants.
Primary source: PharmNet.Bund / BfArM
Official shortage notice for Germany. Responsibility and update procedures follow the information supplied by the relevant authority.
Check the official notice list →